An observational study on the timing of intubation and outcome in COVID-19 ARDS patients who were treated with high flow nasal oxygen prior to invasive mechanical ventilation: A time series analysis (InOutHFNO trial)
Background and Aims: Prolonged high flow nasal oxygen (HFNO) application might delay intubation and increase mortality in acute hypoxemic respiratory failure (AHRF) patients. Intubation in coronavirus disease 2019 (COVID-19) AHRF (CAHRF) patients 24 to 48 hours after HFNO initiation has been associ...
Main Authors: | Rupak Kundu, Sounak Ghosh, Subhash Todi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Indian Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.ijaweb.org/article.asp?issn=0019-5049;year=2023;volume=67;issue=5;spage=439;epage=444;aulast=Kundu |
Similar Items
-
HIGH FLOW NASAL OXYGEN THERAPY (HFNO) IN OPPOSITION TO NON-INVASIVE MECHANICAL VENTILATION (NIV) ADVANTAGES, DISADVANTAGES AND THEIR USE IN COVID-19 INFECTION: BRIEF REVIEW
by: Dmitrovic Radmila, et al.
Published: (2021-12-01) -
High flow nasal oxygen therapy for COVID 19: an unusual complication
by: Tushar Kumar, et al.
Published: (2022-05-01) -
Comments on “Post-extubation high-flow nasal cannula oxygen therapy <em>versus</em> non-invasive ventilation in chronic obstructive pulmonary disease with hypercapnic respiratory failure”
by: Vidushi Rathi
Published: (2023-09-01) -
Comments on "Comparison of immediate withdrawal and stepwise reduction in duration of non-invasive ventilation in chronic obstructive pulmonary disease patients presenting with acute hypercapnic respiratory failure"
by: Vidushi Rathi
Published: (2023-11-01) -
In-Hospital Mortality of COVID-19 Patients Treated with High-Flow Nasal Oxygen: Evaluation of Biomarkers and Development of the Novel Risk Score Model CROW-65
by: Toni Kljakovic Gaspic, et al.
Published: (2021-07-01)